text: a one-dose treatment: where you receive an injection of immunoglobulinat some point during weeks 28 to 30 of your pregnancy
  a two-dose treatment: where you receive two injections; one during the 28th week and the other during the 34th week of your pregnancy
  There doesn't seem to be any difference in the effectiveness between the one-dose or two-dose treatments. Your local clinical commissioning group (CCG) may prefer to use a one-dose treatment, because it can be more efficient in terms of resources and time.
  RAADP is recommended for all pregnant RhD negative women who haven't been sensitised to the RhD antigen, even if you previously had an injection of anti-D immunoglobulin.
  AsRAADPdoesn't offer lifelong protection against rhesus disease,it will be offered every time you become pregnant if you meet these criteria.
  RAADP won't work if youve already been sensitised. In these cases, you'll be closely monitoredso treatment can begin as soon as possible if problems develop.
  After giving birth, a sample of your baby's blood will be taken from the umbilical cord. If you're RhD negative and your baby is RhD positive, and you haven't already been sensitised, you'll be offered an injection of anti-D immunoglobulin within 72 hours of giving birth.
  The injection will destroy any RhD positive blood cells that may have crossed over into your bloodstream during the delivery. This means your blood won't have a chance to produce antibodies and willsignificantly decrease the risk of your next baby having rhesus disease.